Cerenome(DE:XMP1)
€0.59+0.11 (+23.68%)
DE:XMP1
Cerenome financials statements
€0.59
At close:+0.11 (+23.68%)
Cerenome (XMP1) Ratios
3 Followers
Cerenome Ratios
DE:XMP1's free cash flow for Q3 2026 was $-7.72M. For the 2026 fiscal year, DE:XMP1's free cash flow was decreased by $-51.00K and operating cash flow was $-7.67M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.23 | 0.34 | 0.92 | 1.84 | 3.36 |
| Quick Ratio | 1.23 | 0.34 | 0.92 | 1.84 | 3.36 |
| Cash Ratio | 0.71 | 0.00 | 0.80 | 1.53 | 3.13 |
| Solvency Ratio | -1.78 | -0.78 | -1.00 | -1.12 | -1.16 |
| Operating Cash Flow Ratio | -1.69 | -0.68 | -1.20 | -1.09 | -1.75 |
| Short-Term Operating Cash Flow Coverage | -25.78 | -3.21 | -3.23 | -7.55 | -6.39 |
| Net Current Asset Value | $ 2.84M | $ -10.32M | $ -2.90M | $ 4.39M | $ 8.58M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.51 | 0.37 | 0.24 | 0.32 |
| Debt-to-Equity Ratio | 0.21 | -0.38 | -3.10 | 0.89 | 0.65 |
| Debt-to-Capital Ratio | 0.17 | -0.60 | 1.48 | 0.47 | 0.39 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.37 | 0.32 |
| Financial Leverage Ratio | 4.09 | -0.74 | -8.45 | 3.70 | 2.03 |
| Debt Service Coverage Ratio | -4.15 | -1.20 | -2.90 | -7.76 | -4.74 |
| Interest Coverage Ratio | -4.24 | -3.95 | -33.72 | -27.72 | -13.40 |
| Debt to Market Cap | 0.07 | 0.43 | 0.72 | 0.66 | 0.52 |
| Interest Debt Per Share | 1.42 | 26.70 | 1.46 | 3.69 | 9.85 |
| Net Debt to EBITDA | 0.43 | -0.39 | 0.34 | 0.66 | 0.95 |
| Profitability Margins | |||||
| Gross Profit Margin | 91.46% | 85.37% | -97.23% | -217.86% | 0.00% |
| EBIT Margin | -360.20% | -158.89% | -271.14% | -8733.93% | 0.00% |
| EBITDA Margin | -351.66% | -144.27% | -258.36% | -8416.07% | 0.00% |
| Operating Profit Margin | -293.46% | -252.32% | -271.14% | -8800.00% | 0.00% |
| Pretax Profit Margin | -429.43% | -222.84% | -271.04% | -9051.34% | 0.00% |
| Net Profit Margin | -429.43% | -222.84% | -271.04% | -9051.34% | 0.00% |
| Continuous Operations Profit Margin | -429.43% | -222.84% | -271.04% | -9051.34% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 146.33% | 88.32% | 99.96% | 102.86% | 107.26% |
| Return on Assets (ROA) | -137.13% | -195.66% | -116.93% | -84.95% | -60.96% |
| Return on Equity (ROE) | -560.21% | 145.02% | 987.83% | -314.58% | -123.65% |
| Return on Capital Employed (ROCE) | -381.40% | 164.78% | -2015.28% | -164.06% | -77.54% |
| Return on Invested Capital (ROIC) | -317.58% | 263.26% | -280.03% | -142.40% | -70.06% |
| Return on Tangible Assets | -143.32% | -224.07% | -121.34% | -86.64% | -62.15% |
| Earnings Yield | -177.61% | -169.95% | -242.26% | -241.32% | -105.71% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 10.20 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.14 | 0.09 | 2.04 | 0.09 | 0.03 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 15.94 | 11.18 | 4.43 | 0.14 | 0.00 |
| Asset Turnover | 0.32 | 0.88 | 0.43 | 0.01 | 0.00 |
| Working Capital Turnover Ratio | -1.40 | -1.04 | 1.08 | 0.02 | 0.00 |
| Cash Conversion Cycle | -2687.06 | -4022.91 | -179.22 | -4287.72 | -14439.62 |
| Days of Sales Outstanding | 0.00 | 35.79 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 2687.06 | 4058.70 | 179.22 | 4287.72 | 14439.62 |
| Operating Cycle | 0.00 | 35.79 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -6.68 | -39.73 | -4.09 | -7.41 | -12.77 |
| Free Cash Flow Per Share | -6.70 | -40.28 | -4.14 | -7.84 | -12.95 |
| Dividend Paid and CapEx Coverage Ratio | -310.07 | -72.29 | -80.32 | -17.09 | -71.39 |
| Capital Expenditure Coverage Ratio | -310.07 | -72.29 | -80.32 | -17.09 | -71.39 |
| Operating Cash Flow Coverage Ratio | -25.30 | -3.13 | -3.07 | -2.25 | -1.47 |
| Operating Cash Flow to Sales Ratio | -3.99 | -1.81 | -2.62 | -57.91 | 0.00 |
| Free Cash Flow Yield | -165.36% | -140.12% | -236.71% | -163.43% | -82.24% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.56 | -0.59 | -0.41 | -0.41 | -0.95 |
| Price-to-Sales (P/S) Ratio | 2.42 | 1.31 | 1.12 | 37.51 | 0.00 |
| Price-to-Book (P/B) Ratio | 3.15 | -0.85 | -4.08 | 1.30 | 1.17 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.60 | -0.71 | -0.42 | -0.61 | -1.22 |
| Price-to-Operating Cash Flow Ratio | -0.61 | -0.72 | -0.43 | -0.65 | -1.23 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 |
| Enterprise Value Multiple | -0.25 | -1.30 | -0.09 | 0.21 | -0.11 |
| Enterprise Value | 4.67M | 10.93M | 1.12M | -3.96M | 1.27M |
| EV to EBITDA | -0.25 | -1.30 | -0.09 | 0.21 | -0.11 |
| EV to Sales | 0.90 | 1.88 | 0.23 | -17.69 | 0.00 |
| EV to Free Cash Flow | -0.22 | -1.02 | -0.09 | 0.29 | -0.12 |
| EV to Operating Cash Flow | -0.22 | -1.04 | -0.09 | 0.31 | -0.12 |
| Tangible Book Value Per Share | 1.06 | -36.86 | -0.56 | 3.42 | 12.94 |
| Shareholders’ Equity Per Share | 1.28 | -33.69 | -0.43 | 3.68 | 13.47 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 1.68 | 21.93 | 1.56 | 0.13 | 0.00 |
| Net Income Per Share | -7.19 | -48.86 | -4.24 | -11.58 | -16.65 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.19 | 1.40 | 1.00 | 1.04 | 1.07 |
| Research & Development to Revenue | 1.61 | 1.82 | 1.97 | 43.29 | 0.00 |
| SG&A to Revenue | 2.33 | 1.71 | 1.74 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.30 | 0.09 | 0.12 | 2.71 | 0.00 |
| Income Quality | 0.93 | 0.81 | 0.97 | 0.64 | 0.77 |
Currency in USD

